SABBY 13G MBRX 4.23.19

Company

Moleculin Biotech, Inc.

Filed

April 23, 2019

Accession Number

0001535610-19-000082

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →